“ The CEO of Novartis France reveals how the construction of a new French headquarters demonstrates a commitment to develop operations in the country, how the Huningue… ”
In Conversation
“ The general manager of Astellas France and president of LEEM, ”
Interview: Christian Lajoux – President, Fefis (Fédération Française des Industries de Santé), France
“ The President of Fefis, and the recently elected President of Medicen Paris Region, a Paris-based business cluster, talks about the need to build the future of the… ”
Interview: Catherine Bourrienne-Bautista – Director, GEMME (Générique, même medicament – Generics, same medicine), France
“ The director of GEMME reveals how the French generics market is young in comparison to other European countries - where generics were on the market twenty… ”
“ The Chairman & CEO of DBV Technologies reveals how they have developed a new therapeutic method and new technology in the form of a patch to… ”
“ The President of Cristers discusses the history of generic drugs in France and what steps can be taken to increase generics penetration, while also outlining the… ”
“ Yves Bur reveals how the motivation behind his political engagement has been to raise awareness around the importance of improving the social security system. Bur also… ”
“ The General Manager of LEEM talks about the association’s strategy based on three key points, innovation, attractiveness and efficiency; how the Mediator affair has placed a… ”
“ We still have lot of work to do and we need stability if we are to see improvements ”
“ The managing partner of a specialist boutique PR and integrated communications management agency serving the local pharma sector unveils his theory of holistic, industry-wide lobbying and… ”
“ The general manager of a British pharma giant with over 25 years of presence in Romania discusses how vaccination programs can play a significant role in… ”
Interview: Doina Dobjanschi – Senior Director, Clinical Operations & George Badita – VP, Clinical, INC Research Romania
“ The directors of one of the leading in country contract research organisations, explain exactly what makes Romania such an attractive destination for clinical trials. They also… ”